Yifang Zou

Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Vorinostat nanoformulation triggers cell cycle blockade and apoptosis for colorectal cancer therapy.

Vorinostat nanoformulation triggers cell cycle blockade and apoptosis for colorectal cancer therapy.

Journal: International journal of pharmaceutics

Published: April 24, 2026

Nanodelivery of panobinostat induces cell cycle arrest and apoptosis to suppress hepatocellular carcinoma growth in mice.

Nanodelivery of panobinostat induces cell cycle arrest and apoptosis to suppress hepatocellular carcinoma growth in mice.

Journal: Materials today. Bio

Published: April 04, 2025

Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy.

Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy.

Journal: Biomaterials

Published: May 18, 2024

Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma.

Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma.

Journal: International journal of pharmaceutics

Published: March 14, 2024

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.

Journal: Science advances

Published: July 19, 2023

Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.

Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.

Journal: International journal of pharmaceutics

Published: February 14, 2023

Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.

Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.

Journal: International journal of pharmaceutics

Published: November 23, 2022

Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity.

Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity.

Journal: Fundamental research

Published: November 20, 2022

Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy.

Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy.

Journal: Small methods

Published: October 10, 2022

Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.

Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 01, 2022

Role of Hyaluronic Acids and Potential as Regenerative Biomaterials in Wound Healing.

Role of Hyaluronic Acids and Potential as Regenerative Biomaterials in Wound Healing.

Journal: ACS applied bio materials

Published: January 11, 2022

A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

Journal: International journal of pharmaceutics

Published: March 10, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026